Flerie Invest
Investor profile
Flerie Invest has backed 6 European tech companies across 9 funding rounds between 2020 and 2026, joining rounds totalling €230M. Most active in Healthtech. Data as of Nov 2026.
Deals
9
distinct rounds
Companies
6
backed
Active span
2020–2026
7 yrs
Total round €
€230M
sum of rounds joined
Deals by year
distinct rounds / yearFlerie Invest — deals by year — interactive chart.
Data table
| Flerie Invest — deals by year | |
|---|---|
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2026 | 2 |
Top sectors
by dealsFlerie Invest — top sectors — interactive chart.
Data table
| Flerie Invest — top sectors | |
|---|---|
| Healthtech | 9 |
Stages
by dealsFlerie Invest — stages — interactive chart.
Data table
| Flerie Invest — stages | |
|---|---|
| Series A | 4 |
| Series B | 2 |
| Series C | 1 |
| Series D+ | 1 |
| Other | 1 |
Countries
by dealsFlerie Invest — countries — interactive chart.
Data table
| Flerie Invest — countries | |
|---|---|
| Netherlands | 3 |
| Sweden | 2 |
| UK | 2 |
| Iceland | 1 |
| Israel | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Cambridge Innovation Capital2
- Industrifonden2
- IP Group2
- Seventure Partners2
- Tencent2
- Thuja Capital2
- 3B Health Ventures1
- ABC Ventures1
- British Business Bank1
- British Patient Capital1
- C4 Ventures1
- European Innovation Council (EIC)1
- Fredrik and Ann-Helene Ljungström1
- Helsinn Investment Fund1
- Iðunn Venture Fund1
- InnovationQuarter1
- Innovestor Life Science Fund1
- Karolinska Development1
- Ljungström family office1
- LLD Nybohov Invest AB1
- Netherlands Enterprise Agency1
- Novo Holdings1
- Pureos Bioventures1
- RVO.nl1
- Sound Bioventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Microbiotica | UK | 2 | €103M |
| AnaCardio | Sweden | 2 | €77M |
| EpiEndo Pharmaceuticals | Iceland | 1 | €20M |
| KAHR Medical | Israel | 1 | €17M |
| Synerkine Pharma | Netherlands | 2 | €8.8M |
| Amarna Therapeutics | Netherlands | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Microbiotica | Series B | €61M | 2022-03 |
| EpiEndo Pharmaceuticals | Series A | €20M | 2021-08 |
| KAHR Medical | Series D+ | €17M | 2020-02 |
| AnaCardio | Series A | €14M | 2022-09 |
| Synerkine Pharma | Series A | €5.3M | 2023-10 |
| Amarna Therapeutics | Other | €5.0M | 2021-12 |
| Synerkine Pharma | Series A | €3.5M | 2021-12 |